In millions of CHF
| |
2007 |
2006* |
2005* |
2004* |
2003 |
| Zone Europe |
3 412 |
3 109 |
3 082 |
3 395 |
3 561 |
| Zone Americas |
5 359 |
4 946 |
4 364 |
4 142 |
4 150 |
| Zone Asia, Oceania & Africa |
2 697 |
2 571 |
2 334 |
2 538 |
2 508 |
| Nestlé Waters |
851 |
834 |
709 |
666 |
782 |
| Nestlé Nutrition (a) |
1 447 |
1 009 |
932 |
- |
- |
| Pharma (a) |
2 435 |
2 136 |
1 833 |
- |
- |
| Other Food & Beverages (b) |
548 |
371 |
273 |
1 670 |
1 537 |
| EBIT Subtotal |
16 749 |
14 976 |
13 527 |
12 411 |
12 538 |
| Unallocated items (6) |
(1 725) |
(1 674) |
(1 651) |
(1 651) |
(1 532) |
| EBIT Total Group |
15 024 |
13 302 |
11 876 |
10 760 |
11 006 |
* 2006 comparatives have been restated to reflect internal changes in management responsibility as of 1 January 2007. 2005 comparatives have been restated following the first application of the option of IAS 19 Employee Benefits 93A ss. and IFRIC 4. For full details please refer to 2006 Consolidated Financial Statements. 2004 figures restated following first application of IFRS 2 Share-based Payment.
(a) Globally managed nutrition activities are now disclosed separately from the Zones, and pharmaceutical activities separately from Food and Beverages. 2005 comparatives have been restated, including the ones resulting from the decision to transfer the fresh cheese activities in Italy to Nestlé Nutrition. Only dedicated segment assets are allocated to Nestlé Nutrition.
(b) Mainly Nespresso and Food and Beverages Joint Ventures managed on a worldwide basis.
(c) Mainly corporate expenses as well as research and development costs